# Yann Nguyen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yann-nguyen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,189 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 32 |
| i10-index | 63 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5107480121 |
| ORCID iD | 0000-0002-0866-3824 |
| Works | 186 |

## Researcher papers

- [Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19](https://scholariq.org/papers/post-discharge-persistent-symptoms-and-health-related-quality-of-life-after/)
- [Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia](https://scholariq.org/papers/effect-of-tocilizumab-vs-usual-care-in-adults-hospitalized-with-covid-19-and/)
- [Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies](https://scholariq.org/papers/serum-neutralization-of-sars-cov-2-omicron-sublineages-ba-1-and-ba-2-in-patients/)
- [Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial](https://scholariq.org/papers/effect-of-anakinra-versus-usual-care-in-adults-in-hospital-with-covid-19-and/)
- [Epidemiology of Sjögren syndrome](https://scholariq.org/papers/epidemiology-of-sjogren-syndrome/)
- [AI-driven quantification, staging and outcome prediction of COVID-19 pneumonia](https://scholariq.org/papers/ai-driven-quantification-staging-and-outcome-prediction-of-covid-19-pneumonia/)
- [mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants](https://scholariq.org/papers/mrna-vaccination-of-naive-and-covid-19-recovered-individuals-elicits-potent/)
- [Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients](https://scholariq.org/papers/pre-exposure-prophylaxis-with-tixagevimab-and-cilgavimab-evusheld-for-covid-19/)
- [Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19](https://scholariq.org/papers/applicability-of-the-curb-65-pneumonia-severity-score-for-outpatient-treatment/)
- [Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)](https://scholariq.org/papers/eosinophilic-granulomatosis-with-polyangiitis-churg-strauss/)
- [Prior participation as a standardized patient improves OSCE scores of third-year medical students: A pilot comparative study at Université Paris Cité Medical School](https://scholariq.org/papers/prior-participation-as-a-standardized-patient-improves-osce-scores-of-third-year/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Otitis Media and Relapsing Polychondritis](https://scholariq.org/topics/otitis-media-and-relapsing-polychondritis/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.